These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19948031)

  • 1. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src.
    Chung BM; Raja SM; Clubb RJ; Tu C; George M; Band V; Band H
    BMC Cell Biol; 2009 Nov; 10():84. PubMed ID: 19948031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.
    Chung BM; Tom E; Zutshi N; Bielecki TA; Band V; Band H
    World J Clin Oncol; 2014 Dec; 5(5):806-23. PubMed ID: 25493220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants.
    Chung BM; Dimri M; George M; Reddi AL; Chen G; Band V; Band H
    Oncogene; 2009 Apr; 28(16):1821-32. PubMed ID: 19305428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
    Walsh AM; Lazzara MJ
    Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.
    Nishimura Y; Bereczky B; Ono M
    Histochem Cell Biol; 2007 May; 127(5):541-53. PubMed ID: 17361439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells.
    McCann AP; Smyth P; Cogo F; McDaid WJ; Jiang L; Lin J; Evergren E; Burden RE; Van Schaeybroeck S; Scott CJ; Burrows JF
    Cell Commun Signal; 2018 Nov; 16(1):77. PubMed ID: 30409180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line.
    Nishimura Y; Yoshioka K; Bereczky B; Itoh K
    Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells.
    Hu H; Miao XK; Li JY; Zhang XW; Xu JJ; Zhang JY; Zhou TX; Hu MN; Yang WL; Mou LY
    Eur J Pharmacol; 2020 May; 874():172961. PubMed ID: 32044322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
    Nishimura Y; Takiguchi S; Ito S; Itoh K
    Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.
    Yang CH; Chou HC; Fu YN; Yeh CL; Cheng HW; Chang IC; Liu KJ; Chang GC; Tsai TF; Tsai SF; Liu HP; Wu YC; Chen YT; Huang SF; Chen YR
    Biochim Biophys Acta; 2015 Jul; 1852(7):1540-9. PubMed ID: 25912735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion.
    Cheng E; Whitsett TG; Tran NL; Winkles JA
    Mol Cancer Res; 2015 Mar; 13(3):575-83. PubMed ID: 25392346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking.
    Xiao GY; Schmid SL
    PLoS Biol; 2020 Jul; 18(7):e3000778. PubMed ID: 32678845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
    Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
    Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.
    Sutton P; Borgia JA; Bonomi P; Plate JM
    Mol Cancer; 2013 Jul; 12():76. PubMed ID: 23866081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
    Parks EE; Ceresa BP
    J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Src trafficking and activation by the endocytic regulatory proteins MICAL-L1 and EHD1.
    Reinecke JB; Katafiasz D; Naslavsky N; Caplan S
    J Cell Sci; 2014 Apr; 127(Pt 8):1684-98. PubMed ID: 24481818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms.
    Wang T; Zhang J; Wang S; Sun X; Wang D; Gao Y; Zhang Y; Xu L; Wu Y; Wu Y; Liu F; Liu X; Liu S; Zhang Y; Wang Y; Zou L; Liu H
    Cell Commun Signal; 2018 Jul; 16(1):40. PubMed ID: 29976202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
    Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
    Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 20. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.